Bilanz 300 Reichste 2022: Jean-Paul und Martine Clozel | BILANZ
Molecular Millionaire: Jean-Paul Clozel of Actelion
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Jean-Paul Clozel - CEO @ Idorsia - Crunchbase Person Profile
Speakers – Swiss HLG Winter Conference 2018 | by organizers.ch
CEO Daily: Thursday, 26th January | Fortune
Actelion CEO Becomes a Billionaire With J&J's Bid for Drugmaker - Bloomberg
Les 500 plus grandes fortunes de France en 2022 - Challenges
Idorsia will take three to four years to reach profitability, CEO says
Jean-Paul Clozel
Les 500 plus grandes fortunes de France en 2022 - Challenges
Who wants to be a billionaire? Not Actelion's founder and CEO, if it means selling out | Fierce Pharma
Forbes USA March 2018 by Omar Estrada - Issuu
Les français les plus fortunés de Suisse : les surprises du classement - Challenges
Billionaires Buy Merck Site to Build Swiss Biotech Campus | Science | AAAS
Johnson & Johnson's $30 Billion Actelion Deal Is Finally Happening | Fortune
5 éditeurs parmi les 500 plus grandes fortunes de France - Livres Hebdo
New Suitor Reportedly Replaced J&J in This $20 Billion Biotech Deal | Fortune
Martine and Jean-Paul Clozel, the star couple of the world pharmacy - News in France
Deux stars de la biotech suisse réussissent une brillante entrée en bourse | 24 heures
Jean-Paul Clozel - CEO, Idorsia - PharmaBoardroom
Jean-Paul Clozel et Martine Clozel - Les 500 plus grandes fortunes de France - Challenges
Wirtschafts-Deal des Jahres - Der Mann, der es tat – Jean-Paul Clozel verkaufte seine Actelion: «Manchmal packt mich Wehmut»
La Suisse a vu, en 2017, plus de milliardaires partir qu'arriver - SWI swissinfo.ch
Novo Nordisk CEO Lars Sorensen Named World's 'Best-Performing CEO' | Fortune
Novo Nordisk CEO Lars Sorensen Named World's 'Best-Performing CEO' | Fortune
From Actelion to Idorsia: The entrepreneurial journey of Jean-Paul Clozel & Martine Clozel
